The Market Reports

Synopsis

The global market for Oligo Synthesis was estimated to be worth US$ 700 million in 2024 and is forecast to a readjusted size of US$ 1492 million by 2031 with a CAGR of 11.6% during the forecast period 2025-2031.

Oligo synthesis, also known as oligonucleotide synthesis, is a laboratory technique used to chemically synthesize short sequences of nucleic acids, typically DNA or RNA oligonucleotides. These oligonucleotides are composed of relatively short chains of nucleotides, usually less than 100 bases in length. Oligos (or oligonucleotides) are commonly used as primers in PCR (polymerase chain reactions) to selectively amplify target DNA sequences. They can be tagged with fluorescent dyes or radioisotopes for detection purposes. Oligos are often used in DNA sequencing, gene synthesis, and genetic testing, and can be modified for gene therapies or gene expression.

Global key players of Oligo Synthesis include Thermo Fisher Scientific, Merck, Genscript, BBI Life Sciences, Integrated DNA Technologies (IDT), etc. The top five players hold a share about 44%. North America is the largest market, and has a share about 53%, followed by Asia-Pacific and Europe with share 25% and 15%, separately. In terms of product type, Common Primer Synthesis is the largest segment, occupied for a share of 64%. In terms of end user, Biotech Company has a share about 75 percent.

This report aims to provide a comprehensive presentation of the global market for Oligo Synthesis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oligo Synthesis by region & country, by Type, and by End User.

The Oligo Synthesis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligo Synthesis.

Market Segmentation

By Company

• Thermo Fisher Scientific
• Merck
• Azenta Life Sciences
• BBI Life Sciences
• TriLink BioTechnologies
• Aurigene Pharmaceutical Services
• Integrated DNA Technologies (IDT)
• Cusabio
• Macrogen
• Synbio Technologies
• Eurogentec
• Genscript
• Abace Biotechnology
• Tsingke
• Guangzhou RiboBio
• Atantares
• Wuhan GeneCreate Biological Engineering
• Beyotime
• General Biol
• Biosune

Segment by Type

• Common Primer Synthesis
• Modified Primer Synthesis

Segment by End User

• Biotech Company
• Academic Scientific Research Institution

Segment by Region

• North America: United States, Canada, and Mexico
• Europe: United Kingdom, Germany, France, Spain, Italy, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, and Rest of Asia Pacific
• Middle East & Africa: Saudi Arabia, South Africa, and Rest of MEA
• Latin America: Brazil, Argentina, and Rest of Latin America

*If you need a regional or country-specific version, or customized segmentation, we can tailor the report to your requirements.